SCHEMBL7984672

SCHEMBL7984672

O=C1c2cc(O)c(O)cc2-c2ccc(O)c(O)c21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.65
MAOA P21397 6/20 0.64
MEN1 O00255 5/20 0.64
MAPT P10636 5/20 0.64
KMT2A Q03164 5/20 0.64
ALDH1A1 P00352 4/20 0.64
MAPK1 P28482 4/20 0.64
KDM4E B2RXH2 3/20 0.64
CYP3A4 P08684 3/20 0.64
HPGD P15428 3/20 0.64
ALOX15 P16050 3/20 0.64
RECQL P46063 3/20 0.64
HSD17B10 Q99714 3/20 0.64
TDP1 Q9NUW8 3/20 0.64
APEX1 P27695 2/20 0.64
BRCA1 P38398 2/20 0.64
THRB P10828 2/20 0.64
USP2 O75604 1/20 0.64
RAF1 P04049 1/20 0.64
TP53 P04637 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31177135 1.00 TTR (0.65) TTRMAOAMEN1MAPTKMT2A
SCHEMBL31253344 1.00 TTR (0.65) TTRMAOAMEN1MAPTKMT2A
SCHEMBL9350283 0.92 TTR (0.76) TTRMAOAMEN1MAPTKMT2A
SCHEMBL2772226 0.84 MAPT (0.86) TTRMAOAMEN1MAPTKMT2A
SCHEMBL31177134 0.79 MAPT (0.85) TTRMAOAMEN1MAPTKMT2A
SCHEMBL7983966 0.79 MAPT (0.85) TTRMAOAMEN1MAPTKMT2A
SCHEMBL13064957 0.79 TTR (0.74) TTRMAOAMEN1MAPTKMT2A
SCHEMBL30695849 0.79 TTR (1.00) TTRMAOAMEN1MAPTKMT2A
SCHEMBL1507679 0.79 TTR (1.00) TTRMAOAMEN1MAPTKMT2A
SCHEMBL1495097 0.79 TTR (1.00) TTRMAOAMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509413-B2 Method for making a di(aminoaryl)fluorene compound CYTEC INDUSTRIES INC. (US) 2025-12-30 US disclosed
EP-3898573-B1 METHOD FOR MAKING A DI(AMINOARYL)FLUORENE COMPOUND CYTEC IND INC (US) 2025-05-28 EP disclosed
US-20230278948-A1 METHOD FOR MAKING A DI(AMINOARYL)FLUORENE COMPOUND CYTEC INDUSTRIES INC 2023-09-07 US disclosed
US-11685707-B2 Method for making a di(aminoaryl)fluorene compound CYTEC INDUSTRIES INC 2023-06-27 US disclosed
US-20220064099-A1 Method for Making a Di(aminoaryl)fluorene compound CYTEC INDUSTRIES INC 2022-03-03 US disclosed
CN-113302177-A Method for producing bis (aminoaryl) fluorene compound 塞特工业公司 2021-08-24 CN disclosed
US-6194439-B1 ANTICANCER AGENT PFIZER INC. 2001-02-27 US disclosed
EP-0586608-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER INC. (US) 1994-03-16 EP disclosed
WO-1992021660-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER, INC. (US) 1992-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278948-A1 METHOD FOR MAKING A DI(AMINOARYL)FLUORENE COMPOUND F12, F3, F2 TTR 1537/4885MAOA 457/4885MEN1 1191/4885
US-20220064099-A1 Method for Making a Di(aminoaryl)fluorene compound F12, F3, F2 TTR 1263/4885MAOA 348/4885MEN1 1225/4885
US-12509413-B2 Method for making a di(aminoaryl)fluorene compound DAO, FGB, CYP2F1 TTR 1915/4885MAOA 571/4885MEN1 3209/4885
US-11685707-B2 Method for making a di(aminoaryl)fluorene compound F12, F3, F2 TTR 1459/4885MAOA 388/4885MEN1 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.